Literature DB >> 8999465

[Cytokines in systemic lupus erythematosus].

E Robak1, A Sysa-Jedrzejowska, T Robak.   

Abstract

In systemic lupus erythematosus (SLE) is a disease characterized by B cell hyperactivity, autoantibody production and immune complex deposition in vital organs. To explain the mechanisms responsible for immune dysregulation in SLE cytokines have received increasing attention. This review has discussed a number of cytokines which appear to be involved in lupus pathogenesis. Recent studies have shown that disease activity and the main symptoms of SLE are associated with increasing serum levels of cytokines such as interleukin-(IL)-1, IL-2, IL-6, interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (THF-alpha). Constitutive expression and in vitro induction of specific cytokines are also aberrant in SLE. The presence of IL-1, IL-6 and IFN-gamma in involved kidneys suggests that they have local pathogenic effects. Moreover IFN-gamma, IL-6 and IL-1 modulate spontaneous IgG production by SLE mononuclear cells. During the next several years, the exact role of these cytokine in the pathogenesis of lupus become more fully elucidated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8999465

Source DB:  PubMed          Journal:  Przegl Lek        ISSN: 0033-2240


  1 in total

1.  Safety and efficacy of infliximab in a patient with active WHO class IV lupus nephritis.

Authors:  Sawsan J Hayat; Sukhbir S Uppal; M R Narayanan Nampoory; Kaivilayil V Johny; Ramkumar Gupta; Mohammed Al-Oun
Journal:  Clin Rheumatol       Date:  2006-03-25       Impact factor: 3.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.